Rapid Response from Clinical Trials at the Summit: Translating New Evidence Into Retinal Care

0.75CME

45MINS

Overview

Provider Statement

This continuing education activity is provided by

Support Statement

This activity is supported by an educational grant from Genentech, a member of the Roche Group.

Activity Description

Second-generation anti-vascular endothelial growth factor (VEGF) therapies and emerging agents with novel mechanisms of action may expand treatment options for patients with retinal diseases when considered within current treatment approaches. Evaluation of data from pivotal clinical trials and real-world studies can help inform clinical decision-making regarding the integration of these agents into practice. However, findings presented at scientific conferences may not always be readily accessible to busy clinicians and healthcare professionals. Timely review and critical appraisal of these data may support evidence-based, individualized management decisions. In this CE activity, experts in the field review recent clinical trial and real-world evidence presented during the Clinical Trials at the Summit Annual Meeting, including data related to treatment durability, safety, and efficacy. They also discuss the potential clinical implications of newer and investigational therapies for the management of patients with retinal diseases.

Target Audience

The intended audience for this activity is retina specialists and ophthalmologists involved in the management of patients with retinal disorders.

Learning Objectives

Upon successful completion of this activity, participants should be better able to:

Evaluate recent clinical trial and real-world evidence to inform treatment durability for patients with retinal diseases.
Assess safety and efficacy data to determine the potential role of newer and investigational therapies for the management of patients with retinal diseases.

Activity Chair

Arshad M. Khanani, MD, MA, FASRS
Managing Partner
Director of Clinical Research
Director of Fellowship
Sierra Eye Associates
Clinical Professor of Surgery
University of Nevada, Reno School of Medicine
Reno, NV

Faculty

Jeremiah Brown Jr, MS, MD
Retina Consultants of Texas, Partner
Principal Investigator
San Antonio, TX

Christina Y. Weng, MD, MBA
Professor & Alice R. McPherson Retina Research Foundation Chair in Ophthalmology
Fellowship Program Director, Vitreoretinal Diseases & Surgery
Baylor College of Medicine, Cullen Eye Institute
Houston, TX

Planner/Reviewer

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP

Accreditation

ACCME Jointly accredited In support of improving patient care, Vindico Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation

Vindico Medical Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This enduring material is approved for 1 year from the date of original release, June 26, 2026, to June 25, 2027.

How to Participate in This Activity and Obtain CE Credit

To participate in this activity, you must read the objectives, answer the polling and pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 2 of the 3 posttest questions correctly. If a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ certificate.

In addition to providing a downloadable certificate, CME Providers accredited by the Accreditation Council for Continuing Medical Education (ACCME) have the ability to transmit CME credit data for all US physicians to an online repository, the ACCME Program and Activity Reporting System (PARS). CME credit data submitted to PARS can be viewed, managed, and tracked by US physicians in "CME Passport," a free, centralized web application. US Physicians who opt-in by providing their medical license number, state of licensure, and date of birth will have their credits automatically reported to the ACCME.

Disclosures

Vindico Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Individuals in a position to control the content of a continuing education activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Relationship information is accurate at the time of content development.

Activity Chair and Faculty report the following relevant financial relationship(s)

Jeremiah Brown Jr., MS, MD
Advisor: Apellis, Genentech, Harrow
Independent Research Contractor: 4DMT, Adverum, Alcon, Apellis, Boehringer Ingelheim, EyeBio, EyePoint, Genentech, jCyte, Kalaris, Ollin, Opthea, Regeneron, Regenxbio

Arshad M. Khanani, MD, MA, FASRS
Consultant: 4DMT, AbbVie, ADARx, Adverum, Alcon, Alkeus, Allgenesis, Amgen, Annexin, Annexon, Apellis, Ashvattha, Astellas, Aviceda, Beacon, Boehringer Ingelheim, Clearside, Complement Therapeutics, Entrada, Exegenesis, EyePoint, Frontera, Genentech, Harrow, i-Lumen, InFocus, IVERIC bio, Janssen, Kriya, Kyowa Kirin, Lexitas, Merit, Nanoscope, Neurotech, Novartis, Ocugen, Ocular Therapeutix, Oculis, Ollin, Opthea, Opus, Perfuse, RecensMedical, Regeneron, Regenxbio, Revive, RevOpsis, Roche, Samsung, Sanofi, Stealth, Sun, Surrozen, Thea, Therini, Unity Bio, Vanotech, Vial, ZipBio
Independent Research Contractor: 4DMT, AbbVie, ADARx, Adverum, Alexion, Annexon, Astellas, Aviceda, Biojiva, Boehringer Ingelheim, Complement, Exegenesis, EyePoint, Genentech, Gyroscope, IVERIC bio, Janssen, Kyowa Kirin, Ocular Therapeutix, Ollin, ONL Therapeutics, Regenxbio, Roche, Sanofi, Vanotech
Stock Options: Ashvattha, Aviceda, Ollin, Perfuse, PolyPhotonix, RecensMedical, RevOpsis, Vial, ZipBio

Christina Y. Weng MD, MBA
Consultant: Alcon, Alimera/ANI, Allergan/AbbVie, Apellis, BVI, DORC/Zeiss, EyePoint, Frontera, IVERIC bio/Astellas, Ocular Therapeutix, Regeneron, Regenxbio

Planner/Reviewer reports the following relevant financial relationship(s)

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.

Vindico Medical Education staff report the following relevant financial relationship(s)

No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.

Unlabeled and Investigational Usage

The audience is advised that this continuing education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.

Accessibility

Vindico Medical Education is committed to providing an inclusive learning environment and ensuring equitable access to our educational content. Our educational activities may include accessibility features, such as captioning, transcripts, reading aloud, and other platform-supported tools, to assist learners.

Participants who require additional accommodation, alternative formats, or assistance accessing content are encouraged to contact us at CME@VindicoCME.com. Vindico will make all reasonable efforts to provide alternative formats in a timely manner.

Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2026 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any Vindico Medical Education continuing education activity does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the FDA. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

Procedures for Reporting Copyright Infringement

If you suspect that any content in this activity violates your copyright, you can request the removal of such content or restrict access to it by contacting our designated copyright agent (as outlined below). In your email, kindly provide the following details:

Specify the copyrighted work you believe has been infringed upon.
Describe the work and, if possible, include the location (eg, URL) of an authorized version of the work.
Share your name, address, telephone number, and, if available, your email address.
Assert that you genuinely believe that the use of the materials in question is not authorized by the copyright owner, its agent, or the law.
Confirm that the information you have provided is accurate and send an attestation, "under penalty of perjury," that you are either the copyright owner or have the authority to act on behalf of the copyright owner.
Provide a signature or its electronic equivalent from the copyright holder or a representative authorized to act on their behalf.

Our agent for copyright issues relating to this web activity is as follows:
Vindico Medical Education, LLC
Attn: Faith Bantivoglio
6900 Grove Road, Building 300
Thorofare, NJ 08086
fbantivoglio@vindicocme.com
or call: 856-994-9400, ext. 614